Guardant Health Incorporation: Shield Colorectal Cancer Screening To Sustain Growth (GH)

I am bullish on Guardant Health, Inc. ( GH ), driven by a collaboration with Quest Diagnostics ( DGX ), which will broaden access to Shield colorectal cancer screening. Under this collaboration, Guardant has access to over 650,000First Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, "First Principles," involves breaking down complex problems to their most basic elements in terms of financial and technology, enabling ...